Yoshihiro Uesawa

55PUBLICATIONS
57CO-AUTHORS
Cheminformatics and quantitative structure-activity relationshipsComputational chemistryPharmacogenomicsCancer therapy (excl. chemotherapy and radiation therapy)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (55)

|Aug 13, 2026
Investigation of Adverse Events Associated with Predicted GnRHR Agonists Using the FAERS Database.

|Jun 12, 2026
Chemical Motifs Associated with FAERS-Derived Severe Cutaneous Adverse Reaction Disproportionality Signals: An Interpretable Pharmacovigilance-Driven Cheminformatics Study.

|Jun 12, 2026
DeepSnap: From Three-Dimensional Molecular Images to Quantitative Structure-Activity Predictions.

|May 27, 2026
Disproportionality Analysis and Timing of Drug-Associated Guillain-Barré Syndrome Onset Based on the Japanese Adverse Drug Event Report Database.

|Mar 28, 2026
Impact of Reporter Type on Signal Detection of Cancer Therapy-Induced Alopecia: A Hypothesis-Generating Study Using the FDA Adverse Event Reporting System.

Airi Yajima, Yoshihiro Uesawa

|Nov 13, 2025
Tumor-specific cytotoxicity of pyrazole-based chalcone derivatives in human oral squamous cell carcinoma cell lines.

Mehtap Tuğrak Sakarya, Halise İnci Gül, Hiroshi Sakagami

Pageof 10

Frequent Collaborators

6 joint publications

Hiroshi Sakagami

5 joint publications

Shinya Toriumi

4 joint publications

Junko Nagai

3 joint publications

Hideaki Mamada